J&J lung cancer initiative will use Optellum’s ‘digital biomarker’ tech
PharmaPhorum is a leading online destination for healthcare and pharmaceutical industry news, insight and debate.PharmaPhorum
J&J teams up with Optellum to improve lung cancer survival rates
EPM’s in-depth journalism drives the conversation on topics shaping the pharma and biopharma industries, from clinical trial to mass production, regulations, and logistics and distribution. EPM delivers the insight, news,…
Optellum, Johnson & Johnson Collaborate on AI-Powered Lung-Health Initiative
Founded in 2012, HIT Consultant is the leading source of healthcare technology news, analysis and insights for healthcare executives, physicians, and providers. Our content provides editorial insights on health IT,…
Optellum Joins J&J’s Lung Cancer Initiative
Reporter: Reed Miller reed.miller@informa.comMedTech Insight
Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment
Today UK News Reporter: Debbie Casey
